These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15085919)

  • 21. [Comment on S. Gabius, H.-J. Gabius: Immune modulating mistletoe therapy by lectin standardization: a double-edged sword?].
    Wetzel D; Mengs U; Schwarz T
    Versicherungsmedizin; 2000 Mar; 52(1):38-40. PubMed ID: 10718092
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study.
    Schumacher K; Schneider B; Reich G; Stiefel T; Stoll G; Bock PR; Hanisch J; Beuth J
    Anticancer Res; 2003; 23(6D):5081-7. PubMed ID: 14981970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cultural adaptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire.
    Huang WW; Zhou FS; Bushnell DM; Diakite C; Yang XH
    Qual Life Res; 2007 Aug; 16(6):991-6. PubMed ID: 17440830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions.
    Reulen RC; Zeegers MP; Jenkinson C; Lancashire ER; Winter DL; Jenney ME; Hawkins MM
    Health Qual Life Outcomes; 2006 Oct; 4():77. PubMed ID: 17022814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.
    Goebell PJ; Otto T; Suhr J; Rübben H
    J Urol; 2002 Jul; 168(1):72-5. PubMed ID: 12050495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of a new measure of quality of life for young people with diabetes mellitus: the ADDQoL-Teen.
    McMillan CV; Honeyford RJ; Datta J; Madge NJ; Bradley C
    Health Qual Life Outcomes; 2004 Nov; 2():61. PubMed ID: 15535888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of an antitumoral effect of immunomodulatory galactoside-specific mistletoe lectin on N-methyl-N-nitrosourea-induced urinary bladder carcinogenesis in rats.
    Kunze E; Schulz H; Ahrens H; Gabius HJ
    Exp Toxicol Pathol; 1997 Aug; 49(3-4):167-80. PubMed ID: 9314050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
    Bocci V
    J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development and psychometric evaluation of a quality of life scale for Korean patients with cancer (C-QOL)].
    Lee EH
    Taehan Kanho Hakhoe Chi; 2007 Apr; 37(3):324-33. PubMed ID: 17615453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a French patient-based health-related quality of life instrument in kidney transplant: the ReTransQoL.
    Gentile S; Jouve E; Dussol B; Moal V; Berland Y; Sambuc R
    Health Qual Life Outcomes; 2008 Oct; 6():78. PubMed ID: 18851730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of care in an IVF programme from a patient's perspective: development of a validated instrument.
    Holter H; Sandin-Bojö AK; Gejervall AL; Wikland M; Wilde-Larsson B; Bergh C
    Hum Reprod; 2014 Mar; 29(3):534-47. PubMed ID: 24287821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revision and psychometric testing of the City of Hope Quality of Life-Ostomy Questionnaire.
    Grant M; Ferrell B; Dean G; Uman G; Chu D; Krouse R
    Qual Life Res; 2004 Oct; 13(8):1445-57. PubMed ID: 15503840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current understanding of mistletoe lectins.
    Schumacher U; Valentiner U
    Drug Discov Today; 2003 Jan; 8(1):17. PubMed ID: 12546982
    [No Abstract]   [Full Text] [Related]  

  • 34. The Ostomy-Q: Development and Psychometric Validation of an Instrument to Evaluate Outcomes Associated with Ostomy Appliances.
    Nafees B; Rasmussen M; LLoyd A
    Ostomy Wound Manage; 2017 Jan; 63(1):12-22. PubMed ID: 28112646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire.
    Sakane Y; Yamaguchi M; Yokoi N; Uchino M; Dogru M; Oishi T; Ohashi Y; Ohashi Y
    JAMA Ophthalmol; 2013 Oct; 131(10):1331-8. PubMed ID: 23949096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer].
    Gerhard I; Abel U; Loewe-Mesch A; Huppmann S; Kuehn JJ
    Forsch Komplementarmed Klass Naturheilkd; 2004 Jun; 11(3):150-7. PubMed ID: 15249749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe.
    Lenartz D; Dott U; Menzel J; Schierholz JM; Beuth J
    Anticancer Res; 2000; 20(3B):2073-6. PubMed ID: 10928154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability, validity and feasibility of quality of life instruments for adult patients with cancer undergoing chemotherapy: result from a systematic review.
    Yip WK; Mordiffi SZ; Ang E
    Int J Evid Based Healthc; 2012 Mar; 10(1):27-52. PubMed ID: 22405415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of an instrument to measure self-efficacy in caregivers of people with advanced cancer.
    Ugalde A; Krishnasamy M; Schofield P
    Psychooncology; 2013 Jun; 22(6):1428-34. PubMed ID: 22941754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.